Drug Interaction Report

Apixaban and Atazanavir: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Atazanavir

Reyataz
+

Apixaban

Eliquis Eliquis®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 11, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 289 documented Apixaban interactions, 252 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Atazanavir can raise apixaban levels and bleeding risk, so your care team may cut your apixaban dose in half or, at the low 2.5 mg dose, avoid the combination. Keep taking both as prescribed and check with your pharmacist or doctor.

Here's what's going on. Apixaban (Eliquis) is a blood thinner that helps prevent clots. Atazanavir (Reyataz) is an HIV medicine that can slow down how your body breaks down and clears apixaban. When apixaban builds up, its blood-thinning effect gets stronger, which raises your chance of bleeding, things like easy bruising, nosebleeds, or bleeding that is hard to stop.

The good news: this is very manageable. Your care team can adjust your apixaban dose and keep an eye on you for any signs of bleeding. Please don't change either medicine on your own, just check in with your pharmacist or doctor so they can tailor the plan for you.

Effect: Increased apixaban exposure and elevated bleeding risk.

Mechanism: Atazanavir (with or without ritonavir) inhibits both P-gp-mediated efflux and CYP3A4-mediated metabolism of apixaban, increasing apixaban AUC/Cmax. Apixaban is an active drug, not a prodrug, so inhibition amplifies its pharmacologic effect.

  • Direction: Increased apixaban effect (pro-hemorrhagic).
  • Evidence: Theoretical; severity rated major.
  • Onset: Unspecified.
  • Management: For apixaban 5 mg or 10 mg BID, reduce dose by 50% with combined P-gp/strong CYP3A4 inhibitors. For apixaban 2.5 mg BID, avoid coadministration. Monitor for bleeding.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Increased apixaban exposure and an increased risk of bleeding

Interaction Deep Dive

Giving atazanavir, whether or not ritonavir is also present, together with apixaban (an oral anticoagulant) can raise apixaban exposure, thereby heightening the potential for bleeding2. When apixaban 5 mg or 10 mg twice daily is combined with agents that act as both P-gp and strong CYP3A4 inhibitors, the apixaban dose should be cut by 50%. If apixaban is being taken at 2.5 mg twice daily, its use alongside combined P-gp and strong CYP3A4 inhibitors should be avoided1.

Why it happens (mechanism)

Inhibition of P-gp-mediated efflux transport of apixaban; inhibition of CYP3A-mediated metabolism of apixaban

How to manage this interaction

This can be managed safely with your care team's help. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise.

  • Your team may adjust your apixaban dose. If you take 5 mg or 10 mg twice daily, the labeled step is to lower the apixaban dose by half while on atazanavir.
  • If you already take the low 2.5 mg twice-daily dose, this combination is generally avoided, so your prescriber may choose a different plan.
  • Watch for and report signs of bleeding: unusual bruising, nosebleeds, blood in urine or stool, or bleeding that won't stop.

Talk with your pharmacist or doctor before making any change so they can individualize this for you.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Apixaban and Atazanavir together?

Atazanavir can raise apixaban levels and bleeding risk, so your care team may cut your apixaban dose in half or, at the low 2.5 mg dose, avoid the combination. Keep taking both as prescribed and check with your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Apixaban and Atazanavir interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Apixaban and Atazanavir interaction managed?

This can be managed safely with your care team's help. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Your team may adjust your apixaban dose. If you take 5 mg or 10 mg twice daily, the labeled step is to lower the apixaban dose by half while on atazanavir. If you already take the low 2.5 mg twice-daily dose, this combination is generally avoided, so y… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Apixaban or Atazanavir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (2)

  1. Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
  2. Product Information: REYATAZ(R) oral capsules, oral powder, atazanavir oral capsules, oral powder. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2023. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.